If you take insulin or a sulfonylurea, adding a GLP-1 can increase the risk of low blood sugar unless you adjust your dose
He YL, Zhang Y, Serra D, Wang Y, Ligueros-Saylan M, Dole WP: Thorough QT study of the effects of vildagliptin, a dipeptidyl peptidase IV inhibitor, on cardiac repolarization and conduction in healthy volunteers
Cardiovascular improvements can be dramatic and life-extending
Women on tirzepatide should aim for at least 1.2 to 1.6 grams of protein per kilogram of body weight daily
N., Gour, A., Sharma, A., Urs, N., Warren, B., & de Lartigue, G
The EMA, which is similar to the FDA, reviewed non-clinical studies, clinical trials, post-marketing surveillance, and the medical literature regarding NAOIN and semaglutide drugs, like Ozempic